Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection [5] (multiple letters)

  1. García-Doval, I.
  2. Yosipovitch, G.
  3. Chan, Y.C.
Journal:
Journal of the American Academy of Dermatology

ISSN: 0190-9622

Year of publication: 2004

Volume: 50

Issue: 5

Pages: 801-802

Type: Letter

DOI: 10.1016/J.JAAD.2003.10.673 GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus